TY - JOUR
T1 - Assessment of Vascular Disease Prevention Practices in Urban Women
AU - Chaturvedi, Seemant
AU - Pieper, David
AU - Levine, Diane L.
AU - Thati, Neeli
AU - Madhavan, Ramesh
AU - Mateo, Maribeth
AU - Cardozo, Lavoisier
AU - Lepczyk, Mary Beth
N1 - Funding Information:
Acknowledgment The study was supported by a medical education grant from Pfizer.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - Background: Women suffer higher rates of death due to stroke compared to men. In addition, previous studies suggest that women are treated less aggressively for vascular risk factors compared to men. We assessed the quality of primary and secondary vascular prevention at multiple primary care sites within a single region. Methods: Women more than age of 40 years were eligible for the study. Data from the electronic medical record at multiple primary care locations (internal medicine, family medicine, and geriatrics) were analyzed to assess quality of vascular preventative care. Specific attention was devoted to use of antithrombotic agents, statins, and estrogen. Results: 1,815 women with a mean age of 61 years were reviewed. Seventy-five percent were African American. Patients in the urban practices had higher rates of vascular risk factors and existing vascular disease (heart disease or stroke) compared to the suburban locations. Seventy-one percent of patients with diabetes were receiving statins. For patients with previous stroke/transient ischemic attack (TIA), the use of antiplatelet agents or statins was <70%. Patients >70 years were more likely to receive antiplatelet agents (51% vs. 30%, p < 0.0001) and statins (p < 0.001). Conclusions: Urban women have higher rates of vascular risk factors and overt vascular disease compared to suburban women. The use of proven secondary prevention medications for patients with prior stroke/TIA was suboptimal. Both primary and secondary prevention should be intensified for urban women.
AB - Background: Women suffer higher rates of death due to stroke compared to men. In addition, previous studies suggest that women are treated less aggressively for vascular risk factors compared to men. We assessed the quality of primary and secondary vascular prevention at multiple primary care sites within a single region. Methods: Women more than age of 40 years were eligible for the study. Data from the electronic medical record at multiple primary care locations (internal medicine, family medicine, and geriatrics) were analyzed to assess quality of vascular preventative care. Specific attention was devoted to use of antithrombotic agents, statins, and estrogen. Results: 1,815 women with a mean age of 61 years were reviewed. Seventy-five percent were African American. Patients in the urban practices had higher rates of vascular risk factors and existing vascular disease (heart disease or stroke) compared to the suburban locations. Seventy-one percent of patients with diabetes were receiving statins. For patients with previous stroke/transient ischemic attack (TIA), the use of antiplatelet agents or statins was <70%. Patients >70 years were more likely to receive antiplatelet agents (51% vs. 30%, p < 0.0001) and statins (p < 0.001). Conclusions: Urban women have higher rates of vascular risk factors and overt vascular disease compared to suburban women. The use of proven secondary prevention medications for patients with prior stroke/TIA was suboptimal. Both primary and secondary prevention should be intensified for urban women.
UR - http://www.scopus.com/inward/record.url?scp=84981328239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84981328239&partnerID=8YFLogxK
U2 - 10.1089/jwh.2015.5598
DO - 10.1089/jwh.2015.5598
M3 - Article
C2 - 27248372
AN - SCOPUS:84981328239
VL - 25
SP - 806
EP - 809
JO - Journal of Women's Health
JF - Journal of Women's Health
SN - 1540-9996
IS - 8
ER -